Tag: 4-Aminopyridine

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to 4-Aminopyridine

Analysts are on the Bearish side about Acorda Therapeutics, Inc. (NASDAQ:ACOR) this week.

Added to Collection on: 2018-03-02 00:07:30

Tags for this article:

Acorda Therapeutics
Finance
NASDAQ
American Center of Oriental Research
4-Aminopyridine
Short
Money
Financial markets
S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details
Acorda Therapeutics (NASDAQ:ACOR) Shares Gap Up to $2.75

Added to Collection on: 2019-12-27 03:18:45

Tags for this article:

Finance
Financial markets
Money
Hedge funds
Acorda Therapeutics
Stock
Price?earnings ratio
4-Aminopyridine
Point72 Asset Management
Acorda Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Millennium Management LLC Acquires Shares of 45535 Acorda Therapeutics Inc (NASDAQ:ACOR)

Added to Collection on: 2020-01-02 20:11:15

Tags for this article:

Acorda Therapeutics
Life Sciences
4-Aminopyridine
Drugs
Biotechnology
Acorda Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Short Interest in Acorda Therapeutics, Inc. (NASDAQ:ACOR) Drops By 26.2% - Defense World

Added to Collection on: 2022-04-17 17:06:20

Tags for this article:

Life Sciences
Acorda Therapeutics
4-Aminopyridine
Short
Price?earnings ratio
Articles
Finance
Acorda Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
StockNews.com Begins Coverage on Acorda Therapeutics (NASDAQ:ACOR)

Added to Collection on: 2022-12-07 20:54:57

Tags for this article:

Life Sciences
Companies
Acorda Therapeutics
Health care
4-Aminopyridine
AbbVie
Acorda Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
StockNews.com Initiates Coverage on Acorda Therapeutics (NASDAQ:ACOR)

Added to Collection on: 2022-10-28 06:47:50

Tags for this article:

Finance
Money
Economy
Alternative investment management companies
Acorda Therapeutics
4-Aminopyridine
Hedge fund
Price?earnings ratio
Financial analyst
Short
Acorda Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Acorda files for bankruptcy, reveals asset sale plan | BioPharma Dive

Added to Collection on: 2024-04-02 16:20:50

Tags for this article:

Acorda Therapeutics
4-Aminopyridine
Stalking horse offer
Bankruptcy
L-DOPA

Click the tags to see associated articles and topics

View Article Details